ال تأثير تدخل الصيدلي على الالتزام ونوعية الحياة والكفاءة الذاتية بين المرضى العراقيين المصابين بداء الذئب الاحمراري

Barber MRW. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(9):515-532. doi: 10.1038/s41584-021-00668-1. DOI: https://doi.org/10.1038/s41584-021-00668-1

Al-rawi Z, Al-shaarbaf H, Al-raheem E, Khalifa SJ. Clinical features of early cases of systemic lupus erythematosus in Iraqi patients. Rheumatology. 1983;22(3):165–171. doi: 10.1093/rheumatology/22.3.165. DOI: https://doi.org/10.1093/rheumatology/22.3.165

Burkhart PV, Sabaté E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh. 2003;35(3):207. DOI: https://doi.org/10.1111/j.1547-5069.2003.tb00001.x

Emamikia S, Gomez A, Ådahl T, von Perner G, Enman Y, Chatzidionysiou K, et al. Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey. Lupus. 2024;33(6):615–628. doi: 10.1177/09612033241242692. DOI: https://doi.org/10.1177/09612033241242692

Abbas HK, Kadhim DJ, Gorial FI, Shareef LG. Assessment of medication-related burden among a sample of Iraqi patients with systemic lupus erythematosus and its relationship with disease activity: a cross-sectional study. F1000Research. 2022;11:970. doi: 10.12688/f1000research.124698.1. DOI: https://doi.org/10.12688/f1000research.124698.2

Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998;28(3):551–558. doi: 10.1017/s0033291798006667. DOI: https://doi.org/10.1017/S0033291798006667

De Souza RR, Marcon SS, Teston EF, dos Reis P, de Souza Campos Seguraço R, Silva ES, et al. Factors influencing quality of life in people with systemic lupus erythematosus. ACTA Paul Enferm. 2021;34:1–10. doi: 10.37689/acta-ape/2021AO01173. DOI: https://doi.org/10.37689/acta-ape/2021AO01173

Ali AS, Mikhael EM, Mohammed SI. Evaluating stress level and its effect on the quality of life among pharmacists working in Baghdad teaching hospitals. Al-Rafidain J Med Sci. 2025;8:92–96. doi: 10.54133/ajms.v8i1.1661. DOI: https://doi.org/10.54133/ajms.v8i1.1661

Bandura A, Freeman WH, Lightsey R. Self-efficacy: The exercise of control. J Cognit Psychother. 1999;13:158–166. doi: 10.1891/0889-8391.13.2.158. DOI: https://doi.org/10.1891/0889-8391.13.2.158

Ugarte-Gil MF, Gamboa-Cardenas RV, Reátegui-Sokolova C, Pimentel-Quiroz VR, Medina M, Elera-Fitzcarrald C, et al. A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort. Lupus Sci Med. 2023;10(1). doi: 10.1136/lupus-2022-000874. DOI: https://doi.org/10.1136/lupus-2022-000874

Chen Y, Chen B, Shen X, Zhou A, Liang Y, Wang Y, et al. A survey of systemic lupus erythematosus patients’ attitudes toward influenza and pneumococcal vaccination in Southwest China. Front Public Health. 2022;10:1018899. doi: 10.3389/fpubh.2022.1018899. DOI: https://doi.org/10.3389/fpubh.2022.1018899

Villaverde Piñeiro L, Cachafeiro Pin AI, Tajes González YM, Neira Blanco P, Arias Fernández L, Vázquez López M, et al. Impact of a pharmaceutical intervention on influenza vaccination in patients receiving treatment with biological medicines. Eur J Hosp Pharm Sci Pract. 2023;31(1):36–39. doi: 10.1136/ejhpharm-2021-003175. DOI: https://doi.org/10.1136/ejhpharm-2021-003175

Oliveira-Santos M, Verani JFS, Camacho LAB, de Andrade CAF, Klumb EM. Effectiveness of pharmaceutical care for drug treatment adherence in women with lupus nephritis in Rio de Janeiro, Brazil: a randomized controlled trial. Lupus. 2019;28(11):1368–1377. doi: 10.1177/0961203319877237. DOI: https://doi.org/10.1177/0961203319877237

Sah SK, Ramaswamy S, Ramesh M. Impact of clinical pharmacist interventions in resolving drug-related problems in patients with systemic autoimmune disorders. J Pharmacol Pharmacother. 2021;12(4):168–171. doi: 10.4103/jpp.jpp_149_21.

Mikhael EM, Hassali MA, Hussain SA, Nouri AI, Shawky N. Pharmacist-led interventional programs for diabetic patients in Arab countries: A systematic review study. Int J Diabetes Dev Countries. 2019;39(4):600–610. doi: 10.1007/s13410-019-00720-7. DOI: https://doi.org/10.1007/s13410-019-00720-7

Mohammed I. Impact of clinical pharmacist intervention on chemotherapy knowledge, attitude , and practice among breast cancer women. J Fac Med Baghdad. 2024;66(1):103–109. doi: 10.32007/jfacmedbagdad.6612221. DOI: https://doi.org/10.32007/jfacmedbagdad.6612221

Mohammed SI, Al-Shadedi MI, Kasim AA. Knowledge, use and recommendation of Iraqi pharmacist toward complementary and alternative medicine. Iraqi J Pharm Sci. 2020;29(1):88–93. doi: 10.31351/vol29iss1pp88-93. DOI: https://doi.org/10.31351/vol29iss1pp88-93

Mohammed SI, Dawood EB, Abaas IS. Perceptions and attitudes of community pharmacists’ towards patient counseling and continuing pharmacy education programs in Iraq. Iraqi J Pharm Sci. 2019;28(2):30–36. doi: 10.31351/vol28iss2pp30-36. DOI: https://doi.org/10.31351/vol28iss2pp30-36

Emamikia S, Gentline C, Enman Y, Parodis I. How can we enhance adherence to medications in patients with systemic lupus erythematosus? Results from a qualitative study. J Clin Med. 2022;11(7). doi: 10.3390/jcm11071857. DOI: https://doi.org/10.3390/jcm11071857

Zhang L, Geng S, Qian L, Ye S, Wang X, Lu G, et al. Multidisciplinary care in patients with systemic lupus erythematosus: a randomized controlled trial in China. Int J Clin Pharm. 2019;41(5):1247–1255. doi: 10.1007/s11096-019-00870-y. DOI: https://doi.org/10.1007/s11096-019-00870-y

Kelly WN, Ho MJ, Smith T, Bullers K, Kumar A. Association of pharmacist intervention counseling with medication adherence and quality of life: A systematic review and meta-analysis of randomized trials. J Am Pharm Assoc. 2023;63(4):1095–1105. doi: 10.1016/j.japh.2023.04.024. DOI: https://doi.org/10.1016/j.japh.2023.04.024

Barr AC, Clowse M, Maheswaranathan M, Eder L, Eudy AM, Criscione-Schreiber LG, et al. Association of hurried communication and low patient self-efficacy with persistent nonadherence to lupus medications. Arthritis Care Res (Hoboken). 2023;75(1):69–75. doi: 10.1002/acr.25030. DOI: https://doi.org/10.1002/acr.25030

Oliveira-Santos M, Verani JF de S, Camacho LAB, de Andrade CAF, Ferrante-Silva R, Klumb EM. Effectiveness of pharmaceutical care for drug treatment adherence in patients with systemic lupus erythematosus in Rio de Janeiro, Brazil: Study protocol for a randomized controlled trial. Trials. 2016;17(1):181. doi: 10.1186/s13063-016-1317-1. DOI: https://doi.org/10.1186/s13063-016-1317-1

Ziadé N, Karam G, Salloum N, Zoghbi M. Transcultural adaptation and validation of the Arabic version of the compliance questionnaire for rheumatology. Acta Sci Orthopaed. 2020;3(10):26–34. doi: 10.31080/ASOR.2020.03.0215. DOI: https://doi.org/10.31080/ASOR.2020.03.0215

WHOQOL - Measuring Quality of Life| The World Health Organization. United Nations ESCAP. Who. 2017:1–19

Sarhan SA, Kamal DE, Hamed MS, Mostafa DI. Validity and reliability of the Arabic version of the Self-Efficacy for Managing Chronic Disease scale in rheumatoid arthritis patients. Clin Rheumatol. 2022;41(10):2967–7295. doi: 10.1007/s10067-022-06183-2. DOI: https://doi.org/10.1007/s10067-022-06183-2

Al-Ameen TM, Al-Metwali BZ. Assessment of adherence and self-efficacy in a sample of Iraqi patients receiving warfarin or direct oral anticoagulants. Al-Rafidain J Med Sci. 2024;6(1):25–33. doi: 10.54133/ajms.v6i1.437. DOI: https://doi.org/10.54133/ajms.v6i1.437

Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract. 2001;4(6):256–262.

Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35(6):630–640. doi: 10.1002/art.1780350606. DOI: https://doi.org/10.1002/art.1780350606

Rawi ZS Al, Mohammed NA, Ibrahim HA. Factors influencing medication adherence among female patients with systemic lupus erythematosus in Iraq. Int J Sci Res. 2024;13(12):1014–1021. doi: 10.21275/SR241213171931. DOI: https://doi.org/10.21275/SR241213171931

Mohammed RS, Al-jobori SS, Altemimi ZH. Quality of life among patients with systemic lupus erythematosus and its association with sociodemographic and clinical parameters in Karbala governorate. Karbala J Med. 2024;2746–2754. doi: 10.70863/karbalajm.v17i2.1951. DOI: https://doi.org/10.70863/karbalajm.v17i2.1951

Mahmoud H, Abdel Hamid Hawash M, Abd Elmaksoud M. Factors Affecting Adherence of Medication for Patients with Systemic Lupus Erythematous. Egypt J Heal Care. 2022;13(3):1–17. doi: 10.21608/ejhc.2022.249350. DOI: https://doi.org/10.21608/ejhc.2022.249350

Ganachari MS, Almas SA. Evaluation of clinical pharmacist mediated education and counselling of systemic lupus erythematosus patients in tertiary care hospital. Indian J Rheumatol. 2012;7(1):7–12. doi: 10.1016/S0973-3698(12)60003-X. DOI: https://doi.org/10.1016/S0973-3698(12)60003-X

Sah SK, Subramanian R, Ramesh M, Chand S. Impact of pharmacist care in the management of autoimmune disorders: A systematic review of randomized control trials and non-randomized studies. Res Social Adm Pharm. 2021;17(9):1532-1545. doi: 10.1016/j.sapharm.2020.12.005. DOI: https://doi.org/10.1016/j.sapharm.2020.12.005

Sah S, Madhan R, Subramanian R. Initiation of clinical pharmacist services for identification and resolution of drug related problems and detecting their predictors in systemic lupus erythematosus. Value Heal. 2020;23:S746–747. DOI: https://doi.org/10.1016/j.jval.2020.08.2031

Yip SWY, Chong GCH. The role and responsibility of clinical pharmacists in rheumatology clinic: An exploratory study in Hong Kong. Asia Pacific J Heal Manag. 2020;15(2):1–6. doi: 10.24083/apjhm.v15i2.391. DOI: https://doi.org/10.24083/apjhm.v15i2.391

Conti L, Wirth F, Azzopardi L, Mallia C, Vassallo F, Coleiro FC, et al. Pharmaceutical care aspects in systemic lupus erythematosus. Hosp Pharm Eur. 2009;43:48–51.

Abdelrahman BM, Fathy AT, Sabry SS. Effect of continuous care model on self-care practices and quality of life of patients with systemic lupus erythematosus. Egypt J Nurs Health Sci. 2023;4(2):205–232. doi: 10.21608/ejnhs.2023.319002. DOI: https://doi.org/10.21608/ejnhs.2023.319002

Setiawati MCN, Kertia N, Puspitaningrum I. Systemic Lupus erythematosus outpatients medication knowledge and quality of life. J Pharm Sci Clin Res. 2023;8(1):106. doi: 10.20961/jpscr.v8i1.65344. DOI: https://doi.org/10.20961/jpscr.v8i1.65344

Shareef J, Kripa GS, Baikunje S. Impact of pharmacists’ counseling on quality of life in patients undergoing hemodialysis in a tertiary care teaching hospital. World J Nephrol Urol. 2014;3:143–150. doi: 10.14740/wjnu188w. DOI: https://doi.org/10.14740/wjnu188w

Alkashaf KH, Mohammed SI. Impact of clinical pharmacist-led interventions on short term quality of life among breast cancer women taking chemotherapy. Iraqi J Pharm Sci. 2024;33(4):166–173. doi: 10.31351/vol33iss4pp166-173. DOI: https://doi.org/10.31351/vol33iss4pp166-173

Azmi NL, Ahmad SS, Sia R, Lin G, Nur T, Ku E, et al. Impact of educational aid in pharmacist counselling on quality of life in psoriasis patients. Diabetes Metab Syndr Obes. 2019;2(2):48–51. doi: 10.2147/DMSO.S232958. DOI: https://doi.org/10.2147/DMSO.S232958

Omar H, Mohammed H, Ali N, Adel M. The Impact of pharmaceutical care services on patients with active rheumatoid arthritis: A randomized controlled study. Arch Pharm Sci Ain Shams Univ. 2022;6(1):141–155. doi: 10.21608/aps.2022.143040.1092. DOI: https://doi.org/10.21608/aps.2022.143040.1092

Bahap-Kara M, Sariyildiz E, Yardimci GK, Karadag O, Bayraktar-Ekincioglu A. Addressing glucocorticoid-related problems with the clinical pharmacist collaboration in rheumatology practice: A prospective follow-up study. Rheumatol Ther. 2024;11(4):1043–1055. doi: 10.1007/s40744-024-00692-z. DOI: https://doi.org/10.1007/s40744-024-00692-z

Ahmed RA, Ahmed W, Ali S, Mohamed SN. Effect of self-care guidelines on health outcomes and self-efficacy among patients with systemic lupus erythematosus. Egypt J Nurs Health Sci. 2023;4(2):286–327. doi: 10.21608/ejnhs.2023.319235. DOI: https://doi.org/10.21608/ejnhs.2023.319235

Kankaya H, Karadakovan A. Effects of web-based education and counselling for patients with systemic lupus erythematosus: self-efficacy, fatigue and assessment of care. Lupus. 2020;29(8):884–891. doi: 10.1177/0961203320928423. DOI: https://doi.org/10.1177/0961203320928423

Barat E, Soubieux A, Brevet P, Gerard B, Vittecoq O, Lequerre T, et al. Impact of the clinical pharmacist in rheumatology practice: A systematic review. Healthcare. 2024;12(15):1463. doi: 10.3390/healthcare12151463. DOI: https://doi.org/10.3390/healthcare12151463

Sim JJL, Lim CC. Influenza vaccination in systemic lupus erythematosus: Efficacy, effectiveness, safety, utilization, and barriers. Am J Med. 2022;135(3):286-296.e9. doi: 10.1016/j.amjmed.2021.08.038. DOI: https://doi.org/10.1016/j.amjmed.2021.08.038

Le LM, Veettil SK, Donaldson D, Kategeaw W, Hutubessy R, Lambach P, et al. The impact of pharmacist involvement on immunization uptake and other outcomes: An updated systematic review and meta-analysis. J Am Pharm Assoc. 2022;62(5):1499-1513.e16. doi: 10.1016/j.japh.2022.06.008. DOI: https://doi.org/10.1016/j.japh.2022.06.008